No. of patients |
255 |
Median age (yr) |
56.0 ± 13.2 (range, 18-89) |
Gender (male/female) |
205/50 |
Disease (HCC/MHC/CCC) |
212/39/4 |
Background liver disease (HBV/HCV/no infection) |
168/5/82 |
Patients with liver cirrhosis n (%) |
172 (67.5) |
Portal vein invasion (no/yes) |
25/230 |
Alphafetoprotein (0-5/5-400/> 400 ng/mL) |
88/92/75 |
Child-Pugh classification (A/B/C) |
231/22/2 |
ALT (U/L) |
47.6 ± 2.5 |
AST (U/L) |
54.7 ± 3.0 |
Total bilirubin (umol/L) |
27.4 ± 7.1 |
Serum albumin (g/L) |
38.9 ± 0.3 |
Tumor stage |
425 |
Number of tumors (uninodular/multinodular) |
148/107 |
Size of tumor (cm) |
5.1 ± 3.4 (range, 1.3- 20) |
Diagnosis (histopathologic/clinical) |
215/210 |
Treatment |
350 |
Choice of approach (percutaneous/ laparoscopy/laparotomy) |
257/7/86 |
Combination with TACE or PEI (+/-) |
61/194 |